160
Participants
Start Date
July 28, 2011
Primary Completion Date
May 8, 2012
Study Completion Date
May 8, 2012
Evolocumab
Administered by subcutaneous injection
Ezetimibe
Administered orally once a day
Placebo to Evolocumab
Administered by subcutaneous injection
Research Site, Uccle
Research Site, Brussels
Research Site, Camperdown
Research Site, Sydney
Research Site, Ballerup Municipality
Research Site, Melbourne
Research Site, Perth
Research Site, Vejle
Research Site, New York
Research Site, Chevy Chase
Research Site, Raleigh
Research Site, Atlanta
Research Site, Atlanta
Research Site, Savannah
Research Site, Bristol
Research Site, Reus
Research Site, Reus
Research Site, Akron
Research Site, Cincinnati
Research Site, Zaragoza
Research Site, Zaragoza
Research Site, Butte
Research Site, Henderson
Research Site, Las Vegas
Research Site, OYS
Research Site, Westlake Village
Research Site, Mission Viejo
Research Site, Anaheim
Research Site, Auburn
Research Site, Saint John’s
Research Site, St. John's
Research Site, Lachine
Research Site, Helsinki
Research Site, Barcelona
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, L'Hospitalet de Llobregat
Research Site, Göteborg
Research Site, Gothenburg
Research Site, Lund
Research Site, Stockholm
Research Site, Stockholm
Lead Sponsor
Amgen
INDUSTRY